• Auxilium’s AMP-1 printer will support regenerative medicine and implantable device R&D in microgravity aboard the commercial station. • Starlab Space LLCannounced a partnership withAuxilium Biotechnologies. • This agreement represents a significant advancement in 3D bioprinting and biofabrication in orbit and underscores Starlab’s commitment to growing scientific discovery beyond the limits of Earth. • Auxilium will provide orbital 3D bioprinting and biofabrication capabilities aboard the Starlab space station to support advanced research, device development and manufacturing workflows in regenerative medicine, implantable medical technologies and complex tissue engineering applications. • Auxilium’s proprietary AMP-1 3D bioprinter has demonstrated the mass production of implantable medical devices and other complex structures, such as perfusable blood vessels, in microgravity aboard the International Space Station. • With Starlab, Auxilium will accelerate translation from experimental biology to manufacturable products, positioning AMP-1 as a production facility for the next generation of life science technologies in space.
Article Summaries:
- Auxilium’s AMP-1 printer will support regenerative medicine and implantable device R&D in microgravity aboard the commercial station. Starlab Space LLC announced a partnership with Auxilium Biotechnologies. This agreement represents a significant advancement in 3D bioprinting and biofabrication in orbit and underscores Starlab’s commitment to growing scientific discovery beyond the limits of Earth. Auxilium will provide orbital 3D bioprinting and biofabrication capabilities aboard the Starlab space station to support advanced research, device development and manufacturing workflows in regenera
Sources: